Dublin, Edinburgh, London (GMT)

China's Innovation Moment\nFrom cross-border deals to newcos, faster clinical data is fueling the China innovation story, turning biopharmas from Shanghai to Beijing into global players. Multinational pharma and Western VCs have been the first to capitalize, sourcing innovation from China at record levels.\nBut testing faster in humans is also a recipe for Western and Asia biotechs to de-risk their own compounds, working with China partners.\nThis October, BioCentury, BayHelix and Insights Partner McKinsey & Company invite you to visit Shanghai for the 12th China Healthcare Summit. \nGet a firsthand look at China's biotech ecosystem and build your network with the right biopharmas, investors and CDMOs.

Learn more about the China Healthcare Summit, who you will meet, the schedule-at-a-glance and more.

### BioCentury China Healthcare Summit Podcast: Preview<br>
Listen to "BioCentury This Week" for a preview of the BioCentury China Healthcare Summit with special guests.<br><br>

<div style="max-width:860px">
<div id="cincopa_98dbc3"></div><script type="text/javascript">
var cpo = []; cpo["_object"] ="cincopa_98dbc3"; cpo["_fid"] = "AEHAXr_4pVRU";
var _cpmp = _cpmp || []; _cpmp.push(cpo);
(function() { var cp = document.createElement("script"); cp.type = "text/javascript";
cp.async = true; cp.src = "https://rtcdn.cincopa.com/libasync.js";
var c = document.getElementsByTagName("script")[0];
c.parentNode.insertBefore(cp, c); })(); </script></div>

Build your network with the right biopharmas, investors & CDMOs

The time to meet in China is now - Join us in Shanghai

CEO, China

Vivian Bian

Managing Partner & Head of Asia

Amit Kakar

Chairman & CEO

Jing Lou, Ph.D.

Co-Founder, Chairman & CEO

Michelle Xia, Ph.D.

Michael Yu, Ph.D.

Founder & CEO

John Zhu, Ph.D.            

Head of Corporate Alliances & Business Development

Joshua Berlin

VP, Head BD&L and Alliance Management, Oncology and Radiology

Deepa Talpade, Ph.D.

Founder, CEO & Chief Investment Officer

Bin Li, Ph.D.

Senior Director, Search & Evaluation                

Ming Fang

Head, Strategic Initiatives, Global Business Development 

Alex Cogdill, Ph.D.

Joan Shen, M.D., Ph.D.

Chief Business Officer  

Jun Bao, Ph.D.

Co-Chairman

Dan Zhang, M.D. 

Partner

Kevin Wu, Ph.D.

Executive Director

Daniel Ying

Co-Founder & CEO

Piers Ingram, Ph.D.

Fangning Zhang

Josie Xi Zhou, PH.D.

Managing Director

Renaud Gabay

Partner & Co-Head of Global Life Sciences Group

Josh Hofheimer

Founder & Chief Scientific Officer, Hope Medicine and Professor

Rui-Ping Xiao, Ph.D.

Vince Deng, Ph.D.

Former CEO

Axel Hoos, M.D., Ph.D

Dongxu Shu, Ph.D.

President, Global R&D

Lianshan Zhang, Ph.D.

Dajun Yang, M.D., Ph.D.

Ting Xu, Ph.D.

Venture Partner

James Li, M.D.

VP, Chair Professor and Dean, School of Medicine

Chen Dong, Ph.D.

Partner & Leader of Asia Life Sciences, Goodwin and Chairwoman, 

Wendy Pan, Ph.D. 

Frank Zhang, Ph.D. 

Jody Tian

Assistant General Counsel, Business Development

Jimmy Zhuang

George Chen, M.D.        

Managing Partner

Portia Ku 

Shanshan Xu, M.D., Ph.D.

President

Chouwen Zhu, M.D.

Partner  

Jieyu Zou

VP, CTO Manufacturing Business Division

Matthew Hewitt, Ph.D.

Co-Founder, President & CEO

Jak Knowles, M.D.      

SJ Lee, Ph.D.

Partner in Charge, Shanghai

Yiming Liu

James C. Lin, D.Phil.

Xuelin (Steve) Wang, Ph.D.

Founder and CEO

Chengbin Wu, Ph.D.

Simone Fishburn, Ph.D.

Head of Daily Global Intelligence

Jeff Cranmer

David Flores

Nisa Leung

Dan Liu, Ph.D.

Crystal Qin, M.D., Ph.D.               

President, Greater China

Wayne Shi

Stella Xu, Ph.D.

Rachel You     

Amit Mookim

President & CEO

Juran Kato, Ph.D.    

Director and Investigator, CIBR (Chinese Institute for Brain Research) and Founder and Chief Scientific Officer, 

Minmin Luo, Ph.D.

Professor, Fudan University and Founding and Managing Partner

Jian ZHANG, Ph.D.

EVP, Chief Business and Strategy Officer

Nicholas Donoghoe, M.D., 

Chairman and CEO

Tony Liu

VP, Lilly China Innovation and Partnerships

Ryan Wang, Ph.D.

Chairwoman, Wego Orthopedics, and SVP

Julia Chen

Regina Hodits

Jean-Pierre Latere, Ph.D.               

General Manager, China

Jie Li, Ph.D.

Head, Global Business Development

Frederic Scaerou  

MEET THE SPEAKERS

What Will I Learn? \nHow are China biotechs generating faster clinical data for their assets?\nWhat policies have China regulators adopted to help accelerate R&D?\nHow can I source innovation from China?\nHow can China de-risk Western and Asia assets via faster clinical data?\nWhat are the top China assets available for licensing or NewCos?\nWhere is China innovation heading next on targets, modalities and indications?\nWhich CDMOs and service providers can help accelerate my pipeline?\nWhat licensing and NewCo opportunities are available in Korea, Singapore and other emerging Asia markets?\n

Guo-Liang Yu, Ph.D.

Senior Partner & Co-Leader of Asia Life Sciences Practice

Franck Le Deu 

Partner and Chief Operating Officer

Debra Yu, M.D. 

Yong Ben, M.D.

Tony Chen

former Chairman, BayHelix, and 

Victor Shi, Ph.D. 

Former Chairman, BayHelix, and Head of Business Development

Jimmy Zhang, Ph.D.

Lin Sun-Hoffman, Ph.D.

Co-Founder & Chairman

Karen Bernstein, Ph.D.

VP & Editor in Chief

 Jay Dong 

 Senior Vice President, Chief Strategy and Corporate Development Officer

Yong-Hui Shi, Ph.D.

Organizing Committee

Present your Story to VCs and Pharma\nAre you a biotech with cutting-edge innovation? Join the Presenting Company Class of 2025 to increase your visibility and drive partnering requests from VCs and BD teams. Limited space - submit your nominations today.\n\nApply to Present >>\n

Deliver Thought Leadership\nShare your insights, elevate your brand and position yourself as a peer in BioCentury's network of biopharma decision-makers.\n\nLearn More >>\n

See China’s innovation moment for yourself

Where faster clinical data drives de-risking and deals

Home

Event Schedule

Speakers

Presenting Companies

Who You Will Meet

Hotel & Travel Information

FAQs

Award Winners

For over a decade, BioCentury, BayHelix, and McKinsey & Company have brought together a C-level biopharma community to debate, network, and partner. 

China Healthcare Summit 2025